In this podcast, members of the EAU Guidelines Panel for RCC Prof. Axel Bex (DE)  and Prof. Jens Bedke (DE), discuss renal cell carcinoma (RCC), with updates on treatments and current trials. 

Prof. Bex and Prof. Bedke talk about what's new in adjuvant treatment for patients with high-risk RCC after radical nephrectomy.  This follows with discussions on the combination and triplet trials, as well as the recent developments in the systemic treatment of advanced RCC.

Other topics include cytoreductive surgery, metastasectomy, systemic therapy and observation.  Lastly, Prof. Axel and Prof. Bedke analyse what the role of Stereotactic Body Radiotherapy (SBRT) in advanced RCC might be.